{"id":"https://openalex.org/W4254549804","doi":"https://doi.org/10.1016/j.jalz.2014.05.219","title":"IC\u2010P\u2010211: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI\u2010PARAMETRIC MRI","display_name":"IC\u2010P\u2010211: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI\u2010PARAMETRIC MRI","publication_year":2014,"publication_date":"2014-07-01","ids":{"openalex":"https://openalex.org/W4254549804","doi":"https://doi.org/10.1016/j.jalz.2014.05.219"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2014.05.219","doi":"https://doi.org/10.1016/j.jalz.2014.05.219","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2014.05.219","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038797180","display_name":"Holly E. Holmes","orcid":"https://orcid.org/0000-0001-8832-8171","observed_orcids":["https://orcid.org/0000-0001-8832-8171"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Holly E. Holmes","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013599788","display_name":"Ozama Ismail","orcid":"https://orcid.org/0000-0002-0871-3924","observed_orcids":["https://orcid.org/0000-0002-0871-3924"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ozama Ismail","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072120186","display_name":"Jack A. Wells","orcid":"https://orcid.org/0000-0002-4171-3539","observed_orcids":["https://orcid.org/0000-0002-4171-3539"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jack Wells","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109304341","display_name":"James M. O\u2019Callaghan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James O'Callaghan","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102478552","display_name":"Nicholas M. Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas Powell","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049968178","display_name":"Tracey K. Murray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tracey Murray","raw_affiliation_strings":["Eli Lilly & Co Ltd Windlesham United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Co Ltd Windlesham United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031396785","display_name":"Zehshan Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zehshan Ahmed","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael O'Neill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael O'Neill","raw_affiliation_strings":["Eli Lilly, Lilly Research Centre, Windlesham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, Lilly Research Centre, Windlesham, United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051822671","display_name":"Emily C. Collins","orcid":"https://orcid.org/0000-0001-9396-536X","observed_orcids":["https://orcid.org/0000-0001-9396-536X","https://orcid.org/0009-0005-7065-7395"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Collins","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065682460","display_name":"Ross A. Johnson","orcid":"https://orcid.org/0000-0002-0024-6700","observed_orcids":["https://orcid.org/0000-0002-0024-6700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ross Johnson","raw_affiliation_strings":["Eli Lilly and Company, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014115446","display_name":"Niall C. Colgan","orcid":"https://orcid.org/0000-0002-6482-0601","observed_orcids":["https://orcid.org/0000-0002-6482-0601"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Niall Colgan","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030599902","display_name":"Mark F. Lythgoe","orcid":"https://orcid.org/0000-0002-4945-0171","observed_orcids":["https://orcid.org/0000-0002-4945-0171","https://orcid.org/0000-0002-8952-7639"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark F. Lythgoe","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038797180"],"corresponding_institution_ids":["https://openalex.org/I45129253"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.1163,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.37928399,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"10","issue":"4S_Part_7","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10378","display_name":"Advanced MRI Techniques and Applications","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tau-pathology","display_name":"tau pathology","score":0.9350000023841858},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9309999942779541}],"concepts":[{"id":"https://openalex.org/C2777739294","wikidata":"https://www.wikidata.org/wiki/Q2397106","display_name":"Tauopathy","level":4,"score":0.712736964225769},{"id":"https://openalex.org/C149550507","wikidata":"https://www.wikidata.org/wiki/Q899360","display_name":"Diffusion MRI","level":3,"score":0.6844605207443237},{"id":"https://openalex.org/C2777179404","wikidata":"https://www.wikidata.org/wiki/Q422442","display_name":"Doxycycline","level":3,"score":0.6529263854026794},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5837734937667847},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.514428436756134},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4405291974544525},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.41405338048934937},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4120199382305145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33188289403915405},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.3219473958015442},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.26636457443237305},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1903432309627533},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.18025287985801697},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16975009441375732},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16839784383773804},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.10383787751197815},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2014.05.219","doi":"https://doi.org/10.1016/j.jalz.2014.05.219","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2014.05.219","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968469075","https://openalex.org/W2325742486","https://openalex.org/W4252478596","https://openalex.org/W1973685603","https://openalex.org/W2206932523","https://openalex.org/W2338934703","https://openalex.org/W2081472287","https://openalex.org/W4255066026","https://openalex.org/W4240813940","https://openalex.org/W2304814819"],"abstract_inverted_index":{"Averting":[0],"and":[1,35,118,137,155,176,184,192,203,221,269,272],"clearing":[2],"the":[3,13,48,110,162,165,240,273],"aberrant":[4],"accumulation":[5],"of":[6,16,27,62,164,247],"tau":[7,28,37,44,67,169,228],"proteins":[8],"in":[9,19,38,65,218,223,230,239],"neurofibrillary":[10],"tangles":[11],"is":[12],"current":[14],"focus":[15],"therapeutic":[17],"strategies":[18],"Alzheimer's":[20],"disease":[21],"(AD).New":[22],"approaches":[23],"for":[24,133,161,187,267],"direct":[25],"targeting":[26],"demand":[29],"safe,":[30],"non-invasive":[31],"methods":[32],"to":[33,167,211,226,232,249,259,277],"detect":[34],"quantify":[36],"vivo":[39],"[1,":[40],"2].":[41],"To":[42],"assess":[43],"progression":[45],"together":[46],"with":[47,72,109,151],"induced":[49],"brain":[50],"pathology,":[51],"we":[52,214],"longitudinally":[53],"applied":[54],"MRI":[55],"on":[56,157],"a":[57,130,158],"conditional":[58],"bigenic":[59],"mouse":[60],"model":[61],"tauopathy,":[63],"rTg4510,":[64,117,173],"which":[66,106],"expression":[68],"can":[69],"be":[70],"supressed":[71],"doxycycline":[73,152,159,212],"[3].":[74],"We":[75],"investigated":[76],"four,":[77],"clinically":[78],"relevant,":[79],"quantitative":[80],"techniques:":[81],"cerebral":[82],"blood":[83],"flow":[84],"(CBF)":[85],"using":[86,94,101,129,140,200],"arterial":[87],"spin":[88],"labelling":[89],"(ASL);":[90],"aggregated":[91],"protein":[92],"detection":[93],"amide":[95],"proton":[96],"transfer":[97],"(APT);":[98],"microstructural":[99],"diffusion":[100,102,222,270],"tensor":[103],"imaging":[104,271],"(DTI),":[105],"were":[107,123,147,179],"compared":[108],"established":[111],"gold":[112],"standard":[113],"structural":[114,138,193],"MRI.":[115],"19":[116],"8":[119],"wild-type(WT)":[120],"litter-matched":[121],"mice":[122],"imaged":[124,180],"at":[125,182,253],"baseline":[126],"(4.5":[127],"months)":[128],"9.4T":[131],"scanner":[132],"ASL,":[134,189],"DTI,":[135,190],"APT":[136,191,268],"data":[139],"parameters":[141],"previously":[142],"described":[143],"[4,5].":[144],"10":[145],"rTg4510":[146,175],"then":[148],"treated":[149],"orally":[150],"hyclate":[153],"(10mg/kg)":[154],"maintained":[156,199],"diet":[160],"remainder":[163],"study":[166],"supress":[168,250],"expression.":[170],"The":[171],"doxycycline-treated":[172],"untreated":[174],"WT":[177,233],"groups":[178],"again":[181],"5.5":[183,254],"7.5":[185,278],"months":[186],"longitudinal":[188],"data.":[194],"During":[195],"imaging,":[196],"anaesthesia":[197],"was":[198,236,264],"1.5-2%":[201],"isoflurane":[202],"1L/min":[204],"O":[205],"2.":[206],"At":[207],"4.5":[208],"months,":[209],"prior":[210],"treatment,":[213],"observed":[215,266],"marked":[216],"changes":[217],"CBF,":[219],"ATP":[220],"rTg4510s":[224],"due":[225],"increased":[227],"pathology":[229],"comparison":[231],"controls.":[234],"This":[235,262],"most":[237],"apparent":[238],"CBF":[241,256],"study.":[242],"Following":[243],"only":[244],"one":[245],"month":[246],"treatment":[248],"tau,":[251],"(imaging":[252],"months),":[255],"had":[257],"returned":[258],"control":[260],"levels.":[261],"pattern":[263],"also":[265],"trend":[274],"continued":[275],"through":[276],"months.":[279]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-05-12T00:00:00"}